Two Kenyan marathoners suspended for doping

Two prominent Kenyan marathoners have been suspended from competition on doping charges, according to a report by Capital Sports. The Athletics Integrity Unit (AIU) has banned Paul Lonyangata for 19 months for use of the drug Furosemide, and Edward Kiprop Kibet has been banned for three years for nandrolone.

? CLASSEMENT OFFICIEL ?

Hommes :

1⃣ – Paul Lonyangata 2:06:10
2⃣ – Stephen Chebogout 2:06:56
3⃣ – Solomon Yego 2:07:13#ParisMarathon pic.twitter.com/11x1Dapyri

— Schneider Electric Marathon de Paris (@parismarathon) April 9, 2017

Lonyangata won the Paris Marathon in 2017 and 2018, and was the third-place finisher in 2019. One week after the 2019 race, he admitted to using the banned substance Furosemide, after it was found in an out-of-competition sample in September. Furosemide is a heart medication, but it is on the World Anti-Doping Agency’s (WADA) list of prohibited substances because it can mask the presence of performance-enhancing drugs.

Lonyangata rose to fame in 2017, not only because he won the Paris Marathon, but because his wife, Purity Rionoripo, won the women’s race on the same day.

Lonyangata will be banned from competition until May 25, 2023. His fellow countryman, Kibet, will be banned from all competition until February 2025, after testing positive for nandrolone, the same substance found in Shelby Houlihan’s sample last year, for which she was given a four-year ban.